|
|
||||||||
American Journal of Clinical Nutrition, Vol 50, 1401-1406, Copyright © 1989 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
DL Tribble, DP Jones, A Ardehali, RM Feeley and D Rudman
Department of Biochemistry, Emory University School of Medicine, Atlanta.
Biosynthesis of cysteine from methionine via the hepatic transsulfuration pathway is impaired in some cirrhotic patients, who therefore might require cysteine in the diet. However, because further metabolism of cysteine also occurs primarily in the liver, the metabolic clearance of this amino acid could be impaired in cirrhosis. We administered oral loads of L-cysteine to cirrhotic patients and healthy volunteers. Plasma cyst(e)ine (free and protein-bound cysteine, and 1/2 cystine) and urinary sulfur-containing constituents were measured at various times postload. Cirrhotic subjects exhibited a greater maximal plasma cyst(e)ine concentration and plasma elimination half-life (t1/2) and a delayed excretion of metabolic end products after an oral L-cysteine load. The postload increase in total plasma cyst(e)ine was accounted for primarily by an increase in the disulfide form (cystine). These studies show that cirrhotics have an impaired ability to clear cyst(e)ine from the plasma.
This article has been cited by other articles:
![]() |
R. A Blanco, T. R Ziegler, B. A Carlson, P.-Y. Cheng, Y. Park, G. A Cotsonis, C. J. Accardi, and D. P Jones Diurnal variation in glutathione and cysteine redox states in human plasma Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1016 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Nkabyo, Y.-M. Go, T. R. Ziegler, and D. P. Jones Extracellular cysteine/cystine redox regulates the p44/p42 MAPK pathway by metalloproteinase-dependent epidermal growth factor receptor signaling Am J Physiol Gastrointest Liver Physiol, July 1, 2005; 289(1): G70 - G78. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |